APA

Hervé P., Wijdenes J., Bergerat J. P., Bordigoni P., Milpied N., Cahn J. Y., Clément C., Béliard R., Morel-Fourrier B. & Racadot E. (19900320). Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10). : Blood.

Chicago

Hervé P, Wijdenes J, Bergerat J P, Bordigoni P, Milpied N, Cahn J Y, Clément C, Béliard R, Morel-Fourrier B and Racadot E. 19900320. Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10). : Blood.

Harvard

Hervé P., Wijdenes J., Bergerat J. P., Bordigoni P., Milpied N., Cahn J. Y., Clément C., Béliard R., Morel-Fourrier B. and Racadot E. (19900320). Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10). : Blood.

MLA

Hervé P, Wijdenes J, Bergerat J P, Bordigoni P, Milpied N, Cahn J Y, Clément C, Béliard R, Morel-Fourrier B and Racadot E. Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10). : Blood. 19900320.